Hinge Health, Inc.
Q2 2026 Quarterly Account Review
Review period: April 1 through June 30, 2026
Review status: Preliminary, pending USPS account data
1. Executive Account Summary
Hinge Health is a San Francisco-based digital healthcare company providing musculoskeletal care through AI-powered exercise therapy, clinicians, computer-vision motion tracking, wearable devices, and in-person provider coordination. The company is publicly traded under the ticker HNGE and lists its headquarters at 455 Market Street in San Francisco.
Hinge Health’s business model creates physical fulfillment requirements in addition to its digital services. Eligible members may receive program equipment at no personal cost, and the company maintains support processes for equipment orders, shipping, replacements, returns, Enso devices, and replacement gel pads.
The most relevant Q2 2026 developments were:
- Launch of a comprehensive Migraine Care Program using the Enso wearable.
- Record first-quarter financial performance and 23% client growth.
- Expansion of HingeSelect to include surgery and postoperative recovery.
- Increased revenue guidance for Q2 and full-year 2026.
- Continued employer and health-plan adoption, increasing the potential population eligible for equipment shipments.
- Continued movement away from mandatory tablets toward bring-your-own-device care, which may reduce some hardware fulfillment while preserving demand for Enso devices, accessories, replacements, and selected program equipment.
Hinge Health reported Q1 2026 revenue of $182.3 million, an increase of 47% from Q1 2025. Its number of clients increased 23% to 2,849, and trailing-12-month calculated billings increased 52% to $769.9 million.
On June 9, Hinge Health raised Q2 revenue guidance to between $200 million and $202 million, representing approximately 45% year-over-year growth at the midpoint. It also raised full-year revenue guidance to between $818 million and $824 million.
Preliminary USPS assessment: Hinge Health’s strongest potential USPS opportunity is healthcare-device and program-equipment fulfillment. This may include Enso wearables, replacement equipment, gel pads, straps, accessories, printed instructions, return kits, and service-recovery shipments. Ground Advantage may fit routine equipment and supplies, while Priority Mail may support urgent replacements or devices needed to begin treatment. The current carrier, fulfillment provider, shipment origins, package characteristics, USPS share, and returns process could not be verified.
2. Quarterly Performance Comparison
USPS account performance
| Metric | Q2 2026 | Q1 2026 | Q2 2025 | Change |
|---|---|---|---|---|
| USPS revenue | Unavailable | Unavailable | Unavailable | Not calculable |
| USPS package volume | Unavailable | Unavailable | Unavailable | Not calculable |
| Average revenue per package | Unavailable | Unavailable | Unavailable | Not calculable |
| Ground Advantage volume | Unavailable | Unavailable | Unavailable | Not calculable |
| Priority Mail volume | Unavailable | Unavailable | Unavailable | Not calculable |
| Enso-device shipments | Unavailable | Unavailable | Unavailable | Not calculable |
| Replacement-equipment volume | Unavailable | Unavailable | Unavailable | Not calculable |
| Returns volume | Unavailable | Unavailable | Unavailable | Not calculable |
| Gel-pad and supply shipments | Unavailable | Unavailable | Unavailable | Not calculable |
| USPS product mix | Unavailable | Unavailable | Unavailable | Not calculable |
Average revenue per package should be calculated as:
USPS revenue ÷ USPS package volume
The Project spreadsheet is required to calculate:
- Q2 2026 versus Q1 2026 revenue and volume.
- Q2 2026 versus Q2 2025 revenue and volume.
- Percentage changes by USPS product.
- Average revenue per package.
- Initial equipment versus replacement shipments.
- Enso versus other program-equipment volume.
- Outbound versus return volume.
- Origin ZIP Code and fulfillment-provider changes.
- Pricing-agreement performance.
- Account engagement and service trends.
Public business-performance comparison
| Company metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $182.3M | $123.8M | +47% |
| GAAP gross margin | 85% | 81% | +4 percentage points |
| GAAP operating income | $32.1M | $13.1M | +144% |
| Non-GAAP operating income | $46.2M | $15.0M | +208% |
| Operating cash flow | $43.1M | $4.9M | Significant increase |
| Clients | 2,849 | 2,311 | +23% |
| Trailing-12-month calculated billings | $769.9M | $507.0M | +52% |
USPS interpretation: Rapid client and revenue growth could expand the number of members eligible for physical equipment, but company financial growth should not be treated as proportional parcel growth. Actual shipment volume depends on member enrollment, program eligibility, device utilization, bring-your-own-device adoption, replacement rates, and employer benefit design.
3. Important Changes and Trends
Expansion of Enso into migraine care
On April 29, Hinge Health launched a comprehensive Migraine Care Program that includes its FDA-cleared Enso wearable. The company said more than 125 clients covering over two million people had already adopted the program.
Potential USPS significance: Expansion into migraine care may create a new category of device shipments involving:
- Enso wearables.
- Gel pads and consumable supplies.
- Replacement devices.
- Printed instructions.
- Customer support and service-recovery shipments.
- Returns or device exchanges.
The number of devices expected to ship was not disclosed.
Strong client growth
Hinge Health ended Q1 with 2,849 clients, up 23% year over year.
Potential USPS significance: More employer and health-plan clients may produce more eligible members and a larger distributed shipping footprint. USPS should determine whether equipment volume is concentrated after annual benefit launches or distributed throughout the year.
Reduced reliance on mandatory tablets
Hinge Health has promoted a bring-your-own-device approach and described mandatory tablets as adding cost and delaying access. Its current platform uses mobile applications, computer vision, and wearable technology.
Potential USPS significance: Tablet shipment volume may decline or remain limited, while smaller equipment and wearable shipments may become more important. USPS should compare past tablet or sensor shipments with current Enso, accessory, and replacement volume.
Replacement-equipment support remains active
Hinge Health’s support center includes equipment ordering, shipping, replacements, and returns. Members whose equipment problems cannot be resolved through troubleshooting may be eligible to receive replacement equipment at no charge.
Potential USPS significance: Replacement shipments are likely service-sensitive because equipment problems can interrupt treatment. Priority Mail may be appropriate for selected replacements, depending on clinical urgency and current service commitments.
Broader care continuum
On June 9, Hinge Health added surgical coordination to HingeSelect, expanding the offering across physical therapy, specialist evaluation, imaging, nonsurgical procedures, prehabilitation, surgery, and postoperative recovery.
Potential USPS significance: The expansion may create additional member communications, postoperative equipment, printed instructions, provider materials, or recovery-related shipments. No physical fulfillment details were publicly disclosed.
4. Relevant Company Developments
April 29, 2026: Migraine Care Program launched
Hinge Health launched a migraine program using Enso for on-demand pain relief, along with trigger management and expert-led prevention. More than 125 clients covering over two million people had adopted the program at launch.
USPS analysis: This is the quarter’s clearest direct shipping trigger. USPS should obtain the projected number of Enso units, gel-pad replenishments, replacements, and returns associated with the program.
May 5, 2026: Record Q1 results reported
Hinge Health reported $182.3 million in revenue, 2,849 clients, 85% gross margin, and substantially increased operating income and cash flow.
USPS analysis: Business growth supports a broader fulfillment discussion, but package volume must be verified independently.
June 3, 2026: Large-scale ROI study released
Hinge Health published results from a study involving more than 200,000 participants across nearly 1,000 employers. It reported average savings of $2,941 per member annually and a 3.0-times return on investment.
USPS analysis: Strong employer-value evidence may support additional client growth and member adoption. Increased adoption could raise equipment shipments, although that impact remains a hypothesis.
June 9, 2026: HingeSelect expanded to surgery
HingeSelect added coordinated surgical and postoperative care to its existing physical therapy, specialist, imaging, and procedure network.
USPS analysis: Integrated surgical care may create additional physical materials or recovery equipment, but no specific parcel program was announced.
June 9, 2026: Financial guidance increased
Hinge Health raised Q2 revenue guidance to $200 million to $202 million and full-year guidance to $818 million to $824 million.
USPS analysis: The raised outlook indicates strong operating momentum and justifies reviewing whether fulfillment capacity, pickup requirements, and inventory levels are increasing.
June 10, 2026: Movement Investor Day held
Hinge Health held its inaugural Investor Day at its Movement conference in Chicago, bringing together employers, health plans, consultants, providers, and clinical experts.
USPS analysis: Conferences may create periodic shipments involving displays, printed materials, demonstration devices, employee kits, and event supplies. This appears secondary to member-device fulfillment.
5. Potential USPS Impact
Ground Advantage
Ground Advantage may be suitable for:
- Initial program equipment.
- Enso devices.
- Gel pads and replacement supplies.
- Straps and accessories.
- Printed instruction materials.
- Routine replacement equipment.
- Promotional or employer-launch kits.
- Nonurgent return kits.
Suitability depends on device value, lithium-battery content, packaging, weight, dimensions, delivery commitments, and existing carrier pricing.
Priority Mail
Priority Mail may support:
- Urgent replacement devices.
- Members unable to continue treatment because of equipment failure.
- Migraine-program launches.
- Employer implementation deadlines.
- Postoperative equipment.
- Service-recovery shipments.
- Replacement supplies needed to avoid treatment interruption.
Returns and reverse logistics
Hinge Health’s support structure explicitly includes equipment returns, replacements, and order management.
Potential USPS opportunities include:
- Prepaid returns.
- Printerless QR-code returns.
- Device exchanges.
- Advanced replacements.
- Consolidated return reporting.
- Return-to-refurbishment routing.
- Equipment recovery when eligibility ends.
- Replacement tracking linked to member support.
The current return carrier and process were not publicly verified.
Gel-pad and consumable replenishment
Hinge Health maintains support content addressing additional Enso gel pads.
Potential USPS significance: Consumable replenishment may create recurring lightweight shipments separate from initial device fulfillment. These may be particularly suitable for Ground Advantage.
Medical-device and battery requirements
Enso is a small wireless wearable device.
USPS should review:
- Whether the device contains a lithium battery.
- Battery capacity and configuration.
- Ground versus air eligibility.
- Required markings and packaging.
- Defective-device returns.
- Damaged-battery procedures.
- Domestic and international restrictions.
No mailability conclusion should be made without actual product specifications and shipping documentation.
Address quality
Hinge Health ships equipment to individual members, potentially including home addresses that differ from employer records.
Address errors could cause:
- Delayed treatment.
- Replacement shipments.
- Lost equipment.
- Privacy concerns.
- Increased support calls.
- Added employer or health-plan expense.
- Duplicate device fulfillment.
Potential USPS solutions include address validation, apartment-unit verification, National Change of Address processing where appropriate, delivery-exception reporting, and returned-package analysis.
Pickup and fulfillment operations
The company’s headquarters address does not establish the physical fulfillment origin. Hinge Health may use one or more contract manufacturers, medical-device logistics providers, warehouses, or third-party fulfillment partners.
USPS should determine:
- All shipment origins.
- Fulfillment-provider identity.
- Daily package volume.
- Client-launch peaks.
- Replacement and replenishment cadence.
- Pickup schedules.
- Container requirements.
- Acceptance scanning.
- Return-processing locations.
- Inventory allocation.
- Carrier-routing authority.
6. Opportunities
1. Enso and Migraine Care fulfillment
Obtain the deployment forecast for the more than 125 clients already adopting Migraine Care and determine:
- Eligible population.
- Expected Enso shipments.
- Enrollment schedule.
- Package characteristics.
- Fulfillment origins.
- Carrier assignment.
- Gel-pad replenishment.
- Replacement and return expectations.
2. Map the complete equipment lifecycle
Separate USPS activity into:
- Initial equipment.
- Enso devices.
- Gel pads.
- Accessories.
- Replacement equipment.
- Advanced exchanges.
- Returns.
- Refurbishment.
- Employer demonstration kits.
- Event and sales samples.
3. Ground Advantage analysis
Compare routine device and supply shipments with current carriers by weight, zone, delivery performance, residential charges, and total cost.
4. Priority service for treatment interruptions
Develop service rules for replacements based on urgency:
- Routine supplies through Ground Advantage.
- Treatment-interruption replacements through Priority Mail.
- Critical exceptions through Priority Mail Express, where appropriate.
5. Printerless returns
Evaluate QR-code or printerless returns for members who need to exchange equipment but may not have access to a printer.
6. Address-quality improvement
Analyze failed deliveries, apartment errors, member relocations, and duplicate shipments.
7. Client-launch forecasting
Create a schedule for major employer and health-plan launches, particularly around annual benefits enrollment and January plan starts.
8. Consumable replenishment program
Measure recurring Enso gel-pad volume and determine whether it can be standardized under a lower-cost USPS service.
9. Medical-device shipping review
Conduct a compliance review involving batteries, packaging, returns, damaged devices, and international requirements.
10. Conference and sales-kit fulfillment
Review equipment and materials shipped for Movement, employer demonstrations, consultant meetings, health-plan presentations, and provider training.
7. Risks and Concerns
- USPS revenue and package-volume data are unavailable.
- The current carrier and fulfillment provider are unknown.
- Shipping decisions may be controlled by an outside medical-device logistics company.
- Bring-your-own-device adoption may reduce tablet and sensor shipments.
- Enso growth may increase device volume, but no shipment forecast was disclosed.
- Medical-device and battery shipments may require specialized preparation.
- Failed or delayed deliveries can interrupt treatment and affect member satisfaction.
- Equipment sent at no cost to members makes transportation and replacement expense a direct cost to Hinge Health or its clients.
- Replacement devices may require faster service than routine shipments.
- Returned devices may contain batteries or require secure handling and refurbishment.
- Member home addresses create privacy, address-quality, and delivery-risk considerations.
- Revenue growth should not be used as a substitute for package-volume data.
- Pricing agreements, pickup arrangements, service issues, and prior commitments remain unavailable.
8. Customer Questions
- What were Hinge Health’s Q2 2026 USPS revenue and package volume compared with Q1 2026 and Q2 2025?
- Which carriers currently handle:
- Initial equipment?
- Enso devices?
- Gel pads?
- Replacement equipment?
- Returns?
- Employer demonstration kits?
- Who controls carrier selection and postage payment?
- Where are U.S. orders fulfilled?
- Which fulfillment providers or medical-device logistics vendors are used?
- What equipment is currently shipped to members?
- How much tablet and motion-sensor volume remains after bring-your-own-device adoption?
- How many Enso devices are expected to ship through the Migraine Care Program?
- What are the average package weights, dimensions, zones, and values?
- Does Enso contain a lithium battery, and how is it currently declared and packaged?
- How often are gel pads or other supplies replenished?
- What percentage of equipment requires replacement?
- What are the leading causes of replacement:
- Technical failure?
- Loss?
- Damage?
- Address error?
- Member eligibility changes?
- Which carrier handles equipment returns?
- Are return labels printerless?
- Are advanced replacements used?
- How many deliveries fail because of incomplete or outdated addresses?
- Do employer launches create predictable shipment spikes?
- What volume is expected around January benefit-plan launches?
- Are there known USPS pickup, scanning, delivery, claims, billing, or return issues?
- When does the current USPS pricing agreement expire?
- Which previous commitments remain open?
9. Recommended Actions
USPS actions
- Retrieve Q2 2026, Q1 2026, and Q2 2025 USPS revenue and volume.
- Calculate quarter-over-quarter and year-over-year changes.
- Calculate average revenue per package.
- Identify all Hinge Health shipment origins, fulfillment partners, CRIDs, permits, and postage-paying entities.
- Obtain a representative all-carrier shipment file.
- Separate Enso, gel-pad, equipment, replacement, return, and event shipments.
- Obtain the Migraine Care deployment forecast.
- Analyze Ground Advantage for routine devices and supplies.
- Analyze Priority Mail for treatment-interruption replacements.
- Evaluate USPS Returns and printerless-label options.
- Conduct a lithium-battery and medical-device mailability review.
- Analyze address-related failed deliveries and duplicate shipments.
- Create an employer and health-plan launch forecast.
- Review pickup capacity and acceptance scans at all fulfillment origins.
- Confirm pricing-agreement expiration and renewal requirements.
- Document service issues, prior commitments, responsible parties, and due dates.
Recommended customer follow-up
Schedule a QAR involving:
- Supply chain and logistics.
- Medical-device operations.
- Enso product management.
- Migraine Care leadership.
- Member support.
- Fulfillment and returns operations.
- Employer implementation.
- Finance and procurement.
- Compliance and quality.
- Third-party fulfillment providers.
The first discussion should focus on Enso growth, equipment lifecycle, carrier allocation, replacement urgency, returns, batteries, address quality, and client-launch forecasts.
10. Salesforce-Ready Account Update
Q2 2026 QAR: Hinge Health is a San Francisco-based digital healthcare company providing AI-supported musculoskeletal care, clinician services, motion technology, and wearable devices. Hinge Health maintains physical equipment-order, shipping, replacement, and return processes for eligible members.
The most significant Q2 development was the April 29 launch of a comprehensive Migraine Care Program using the FDA-cleared Enso wearable. Hinge Health stated that more than 125 clients covering over two million people had adopted the program. The company also reported Q1 revenue of $182.3 million, up 47% year over year, and 2,849 clients, up 23%. On June 9, it raised Q2 revenue guidance to $200 million to $202 million and expanded HingeSelect to include surgery and postoperative recovery.
Potential USPS opportunities include Ground Advantage for Enso devices, gel pads, accessories, and routine equipment; Priority Mail for urgent replacements; printerless returns; address-quality improvement; employer-launch forecasting; and medical-device shipping support.
Risks: USPS performance, carrier allocation, fulfillment locations, and package characteristics were unavailable. Bring-your-own-device adoption may reduce some hardware shipments, while Enso growth may increase wearable and consumable volume. Battery, medical-device, privacy, and treatment-interruption requirements must be addressed.
Next steps: Retrieve quarterly USPS data, identify fulfillment providers and shipment origins, obtain all-carrier package data, quantify Enso and Migraine Care deployments, review replacement and return processes, complete a battery-mailability analysis, and schedule a cross-functional logistics review.
Follow-up date: Not provided.
11. Information Required to Finalize the QAR
- Q2 2026 USPS revenue and package volume.
- Q1 2026 USPS revenue and package volume.
- Q2 2025 USPS revenue and package volume.
- Average revenue per package.
- USPS product-level activity.
- Current carrier mix.
- Fulfillment providers and origins.
- Postage-paying entities.
- Enso shipment volume.
- Migraine Care deployment forecast.
- Gel-pad and accessory volume.
- Initial equipment volume.
- Replacement-equipment volume.
- Return and exchange volume.
- Package weights, dimensions, zones, and values.
- Battery specifications and shipping procedures.
- Address-related failure data.
- Pickup and acceptance arrangements.
- Current pricing agreement.
- Agreement expiration date.
- Known service issues.
- Previous commitments.
- Open opportunities.
- Last meeting and QAR dates.
- Next action and follow-up date.
12. Sources
- Hinge Health, April 29, 2026: Launch of the Migraine Care Program, use of Enso, and adoption by more than 125 clients covering over two million people.
- Hinge Health, May 5, 2026: Q1 revenue, client growth, profitability, calculated billings, cash flow, and initial Q2 guidance.
- Hinge Health, June 3, 2026: Five-year ROI study involving more than 200,000 participants and nearly 1,000 employers.
- Hinge Health, June 9, 2026: Addition of surgery and postoperative recovery to HingeSelect.
- Hinge Health, June 9, 2026: Increased Q2 and full-year revenue guidance and first Investor Day.
- Hinge Health Help Center, reviewed June 30, 2026: Equipment orders, shipping, replacements, returns, and member support.
- Hinge Health Help Center, reviewed June 30, 2026: Replacement-equipment eligibility and no-cost equipment for eligible members.
- Hinge Health company and product information, reviewed June 30, 2026: AI-powered care, Enso, wearable equipment, motion technology, and San Francisco headquarters.